Leukemia, B-cell, Chronic  >>  Genasense (oblimersen)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Genasense (oblimersen) / Genta
NCT00024440: Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Completed
3
US
filgrastim, oblimersen sodium, cyclophosphamide, fludarabine phosphate
Genta Incorporated
Leukemia
 
02/07
NCT00517218: This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)

Withdrawn
3
US
Genasense® (, oblimersen sodium G3139)
Genta Incorporated
Lymphocytic Leukemia
 
06/09

Download Options